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Abstract
Our results show that cytokines derived from macrophages play an important role in pathogenesis of
arthritis triggered by CpG oligodinucleotide (CpG ODN). IL-12 is in this respect an important
immunomodulator during the development of joint inflammation.
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Synopsis
Introduction: Bacterial infections can be localized to the joints,
causing septic arthritis, the most rapidly progressing joint
disease. We have recently shown that unmethylated CpG
motifs of bacterial DNA give rise to arthritis characterized by an
influx of monocytic, Mac-1 antibody positive (Mac-1+) cells and
by a scarcity of T lymphocytes. Cytokines have been shown to
exert an important influence in the pathogenesis of arthritis in
several mouse models. Tumor necrosis factor (TNF)-α, IL-1β,
IFN-γ, and IL-12 are all produced in various quantities in the
joints of patients with rheumatoid arthritis and in experimental
(eg collagen-induced and septic) arthritides.
Aims: To investigate patterns of local cytokine mRNA
expression for IL-1β, IL-12, TNF-α, and IFN-γ in mice with
arthritis induced by CpG ODN and the role of IL-12 in the
development of CpG ODN-induced arthritis.
Methods: CpG ODN was injected into the knee joints of mice,
which were then killed after various intervals (0, 1, 3, 7, 14, or
21 d). At the end of each time interval, the synovial tissues
were excised under an inverted microscope. We analyzed the
mRNA expression of the cytokines in synovial tissue using a
technique of hybridization in situ. IL-12 P40 knockout mice
were used in an analysis of the role of IL-12 in the development
of CpG ODN-induced arthritis.
Results: None of the cytokine mRNAs studied was detected in
the synovia of mice injected intra-articularly with calf thymus DNA
or phosphate-buffered saline solution. In contrast, after intra-
articular injection of CpG ODN, the monocyte/macrophage-
derived cytokines TNF-α, IL-1β, and IL-12 were induced rapidly,
being detected within the first day. The expression of TNF-α
mRNA peaked on day 3 and then decreased, whereas IL-1β
mRNA expression was high from day 1 onwards. IL-12 mRNA
rose to peak values between days 3 and 21. The T helper (Th)1
cytokine IFN-γ mRNA was undetected throughout the
experiment. The arthritis had a lower incidence and was less
severe in IL-12 knockout mice than in their congenic littermates.
The frequency of TNF-α and IL-1β mRNA expression in synovia
was lower at day 3 in IL-12 knockout mice than in wild-type mice,
while IFN-γ mRNA expression was not detectable. In vitro, TNF-α
levels were lower in supernatants from mononuclear cells
originating from IL-12 knockout (IL–/–) mice and incubated with
CpG ODN than in corresponding supernatants originating from
IL-12+/+ mice.
Discussion: Previous studies have shown that bacterial DNA
and CpG ODN directly activate macrophages to secrete
proinflammatory cytokines, such as TNF-α, IL-1β, and IL-12.
These cytokines exert proinflammatory activities in both septic
Introduction
Several reports on the immunostimulatory properties of
bacterial DNA have recently been published. Bacterial
DNA directly activates B cells, monocytes, macrophages,
and dendritic cells in vitro to upregulate their expression of
costimulatory molecules that drive immune responses and
secrete a variety of cytokines, including high levels of inter-
leukin (IL)-12, IL-1, and tumor necrosis factor (TNF)-α
[1–3]. Bacterial DNA indirectly activates natural killer (NK)
cells and T cells [1,4,5], whereas vertebrate DNA lacks
immunostimulatory effects. Unmethylated CpG motifs are
common in bacterial DNA and considerably less common
in vertebrate DNA [6,7]. In addition, whereas CpG motifs
in bacterial DNA are unmethylated, the great majority of C
and G nucleotides are methylated in all eukaryotic organ-
isms, including mammals [6,7]. Unmethylated CpG
oligodinucleotides (CpG ODNs) are responsible for the
immunostimulatory properties of bacterial DNA [8,9].
Our group has recently reported that intra-articular bacter-
ial DNA induces arthritis [10]. Histopathological signs of
the arthritis were evident within two hours and lasted for at
least three weeks, and it was characterized by an influx of
monocytic, Mac-1+ cells and a scarcity of T lymphocytes.
Unmethylated CpG motifs were responsible for the induc-
tion of this arthritis. This proinflammatory effect of bacterial
DNA did not appear to be caused by contamination with
endotoxins, since mice that did not respond to
lipopolysaccharides developed arthritis in response to
CpG ODNs but not in response to non-DNA bacterial
contamination. Neither T cells, B cells, NK cells, nor neu-
trophils were found to be mandatory for induction of
CpG ODN-mediated arthritis, whereas macrophages
played a major role in induction of arthritis triggered by
CpG motifs in bacterial DNA [10].
Cytokines have been shown to exert an important role in the
pathogenesis of arthritis in several mouse models. TNF-α,
IL-1β, IFN-γ, and IL-12 are all produced in various quantities
in the joints of patients with rheumatoid arthritis and in exper-
imental arthritides such as collagen-induced [11–14] and
septic [15] arthritis. These cytokines play an important role in
the induction and development of aseptic and septic arthritis
[16–20]. To better understand the pathogenesis of
CpG ODN-mediated arthritis, we wanted to know more
about the expression and role of these cytokines during its
early phase. We therefore investigated the patterns of local
cytokine mRNA using hybridization in situ and assessed the
role of IL-12 in the induction of CpG ODN-mediated arthritis.
Materials and methods
Mice
C57BL/6 mice were purchased from ALAB (Stockholm,
Sweden). IL-12 P40 knockout mice were kindly provided
by Dr J Magram (Nutley, NJ, USA) [21]. All mice were
housed in the animal facility of the Department of Rheuma-
tology, University of Göteborg. Male mice 6–8 weeks of
age were used in all the experiments.
Oligonucleotides and injection
Phosphorothioate-modified oligonucleotide (CpG ODN)
1668 were synthesized by Scandinavian Gene Synthesis
AB (Köping, Sweden). The sequence of oligodinucleotide
(ODN) 1668 (containing the CpG motif) has been
reported elsewhere [10]: 5′-TCC ATG ACG TTC CTG
ATG CT-3′. CpG ODN (6 µg in a volume of 20 µl) was
injected into the knee joints of the mice.
Tissue preparation
The mice were killed 0, 1, 3, 7, 14, or 21 d after inocula-
tion. At the end of each time interval, the synovial tissues
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and aseptic arthritides. TNF-α is produced primarily by
monocytes and macrophages and stimulates macrophage
production of IL-1. These two cytokines interact synergistically,
stimulating each other’s release and thereby amplifying the
cascade of other inflammatory mediators.
IL-12 too is produced primarily by monocytes/macrophages,
but mostly in response to microbial agents. It induces
differentiation of Th1 cells and the production of IFN-γ by
natural killer and T cells and is involved in the inflammatory
cascade as synovitis develops. Mice that are genetically unable
to produce IL-12 have a decreased incidence of septic arthritis.
The present study shows sustained expression of IL-12 mRNA
in synovia of CpG ODN-triggered arthritis. Histopathological
examination showed that arthritis had a lower incidence and
was less severe in IL-12 knockout mice than in control mice.
Although the differences were not statistically significant, these
findings suggest that IL-12 may play a role in the pathogenesis
of arthritis triggered by CpG ODN.
How does IL-12 participate in the induction of this arthritis?
Our data suggest that TNF-α and IL-1β mRNA are expressed
less strongly in synovial tissue of IL-12 knockout mice than in
that of of wild-type controls. Furthermore, the levels of TNF-α
released in vitro by spleen mononuclear cells in response to
stimulation with CpG ODN were markedly lower in IL-12
knockout mice. IL-12, one of the cytokines produced in joints,
has proinflammatory properties.
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from the joints of four animals were excised under an
inverted microscope. These tissues were then snap-frozen
in OCT™ compound (Tissue-TeK®; Sakura Finetek Europe
B.V., The Netherlands) by immersion in liquid nitrogen.
Frozen tissue was stored at –70°C until use. Serial 6-µm
sections were cut and thaw-mounted onto probe-on-slides
(Fisher Scientific, Pittsburgh, PA, USA).
Hybridization in situ
Hybridization was conducted in situ to analyze cytokine
mRNA expression, as previously detailed [10]. Briefly, syn-
thetic oligonucleotide probes (Table 1) – TNF-α, IFN-γ,
IL-1β, and IL-12 (the gift of Dr Tomas Olsson, Karolinska
Institute, Stockholm, Sweden) – were labeled at the 3′
end using terminal deoxynucleotidyl transferase
(Advanced Biotechnologies, Leatherhead, UK) and
[35S]ATP (Dupont Scandinavia, Stockholm, Sweden).
Sections (6 µm thick) of freshly frozen synovial tissues
were thaw-mounted onto slides and hybridized with
1 × 106 cpm of labeled probe per 100 µl hybridization
mixture. After emulsion autoradiography, development,
and fixation, the coded slides were examined by dark-field
microscopy for positive cells, which were defined as those
containing >15 silver grains in a star-like distribution. The
intracellular distribution of the grains was checked by light
microscopy at higher magnification. The data were
expressed as the number of cells (mean ± SEM) express-
ing mRNA per mm2 of the tissue section.
Histopathological examination
Joints were fixed, decalcified, and embedded in paraffin
for histopathological examination. Tissue sections from
knee joints were cut and stained with hematoxylin–eosin.
All the slides were coded and evaluated blind. The speci-
mens were evaluated with regard to synovial hypertrophy,
pannus formation, and destruction of cartilage and sub-
chondral bone [22].
TNF-α levels in supernatant and serum
Spleen mononuclear cells were prepared as described
previously [20]. The cells (1 × 106/ml) were cultured in
Iscove’s complete medium (10% fetal calf serum,
5 × 10–5 M 2-mercaptoethanol, 2 mM L-glutamine, and
50 µg/ml gentamicin) and stimulated with 1 µg/ml
lipopolysaccharides or 1 µM CpG ODN. The cultures were
maintained in 24-well plates (Nunc; Roskilde, Denmark) at
37°C in 5% CO2 and 95% humidity. The supernatants
were collected after 18 h for determination of TNF-α.
TNF-α levels in supernatant and serum taken from IL-12
knockout and wild-type mice at day 3 after intra-articular
inoculation with 6 µg CpG ODN were analyzed using a
TNF-α ELISA kit (Genzyme, Cambridge, MA, USA).
Statistical analysis
The differences between mean values were tested for sig-
nificance with the Fisher’s Exact test and the Mann–
Whitney U test.
Results
Kinetics of synovial cytokine mRNA expression
Various workers have suggested that locally released
cytokines are a key mediator of the inflammation and joint
destruction observed in inflammatory arthritis [11–15]. To
assess the local induction of cytokines, we analyzed the
expression of their mRNA in synovia, using hybridization in
situ. Figure 1 shows a typical result. None of the cytokine
mRNAs studied were detected in the synovia of mice given
intra-articular injections of calf-thymus DNA or phosphate-
buffered saline solution. In contrast, after intra-articular inoc-
ulation with CpG ODN, the monocyte/macrophage-derived
cytokines TNF-α, IL-1β, and IL-12 were induced rapidly,
being detected within the first day. The expression of TNF-α
mRNA peaked on day 3 and then decreased, whereas that
of IL-1β mRNA rose on day 1 and remained high from then
onwards. IL-12 mRNA rose to peak values between days 3
and 21. The Th1 cytokine IFN-γ mRNA was undetectable
throughout the experiment (Fig. 2a,b).
Histopathological examination
Since IL-12 mRNA expression was high during arthritis
induced by CpG ODN, we studied its role further using
IL-12 knockout mice. The incidence (62.5%) and severity
(0.75 ± 0.75) of arthritis were decreased in IL-12 knockout
mice as compared with their congenic littermates (100%
and 1.33 ± 0.5, respectively) (Fig. 3a,b). These differences










Oligonucleotide probes used for hybridization in situ
Probe Genbank accession no. Complementary to bases Reference
IL-1β M98820 639–686, 69–616, 278–325, 295–342 Feeser and Freimark, 
unpublished data, 1992
TNF-α D00475 913–960, 2059–2106 [41]
IL-12 M86771, M86672 147–194, 595–642 190–238, 706–753 [42]
IFN-γ M29315 298–345, 80–125 303–350, 180–227 [43]
Proinflammatory cytokine mRNA levels
To explore how IL-12 influenced the CpG ODN-triggered
arthritis, synovial tissues taken from the knees of wild-type
and IL-12 knockout mice at day 3 after intra-articular inoc-
ulation with CpG ODN were evaluated for TNF-α, IL-1β,
and IFN-γ mRNA expression using hybridization in situ. As
shown in Fig. 4, the frequency of TNF-α and IL-1β mRNA
expression in synovia was lower at day 3 in IL-12 knockout
mice than in wild-type mice, and IFN-γ mRNA expression
was undetectable.
TNF-α levels in supernatant and serum
To assess why the incidence and severity of CpG ODN-trig-
gered arthritis were decreased in IL-12 knockout mice, we
compared TNF-α levels in IL-12 knockout mice with those in
wild-type mice, using CpG ODN as stimulus in vitro or in
vivo. The reason for this approach is that TNF-α is an essen-
tial mediator of CpG ODN-mediated arthritis [10]. TNF-α
levels in supernatants from mononuclear cells stimulated
with CpG ODN were lower in IL-12 knockout mice than in
the wild-type control mice (Fig. 5). In contrast, the TNF-α
levels were similar in supernatants from mononuclear cells
stimulated with lipopolysaccharides, irrespective of IL-12
phenotype (Fig. 5). This suggests that the TNF-α response
by macrophages to CpG ODN stimulation is at least partly
influenced by expression of IL-12. Serum TNF-α levels col-
lected at day 3 after intra-articular inoculation with 6 µg
CpG ODN from wild-type and IL-12 knockout mice did not
show detectable amounts of this cytokine.
Discussion
Bacterial DNA in general, and unmethylated CpG ODN in
particular, trigger joint inflammation and thus may play a
pathogenic role in septic arthritis. Macrophages partici-
pate in innate cellular immunity and initiate many host
defense responses. How does CpG ODN activate
macrophages and induce arthritis? Previous studies have
demonstrated that bacterial DNA and CpG ODN activate
macrophages directly [23]. The first step of activation
comprises the uptake of bacterial DNA or synthetic
oligonucleotides by macrophages in a saturable, sequence-
independent, temperature- and energy-dependent fashion
[24,25] into an acidified intracellular compartment, where
DNA becomes degraded to oligodeoxynucleotides [26].
Once there, unmethylated CpG dinucleotides activate the
stress-kinase/jun pathway within minutes, yielding tran-
scriptionally active activating protein-1 and NF-κB [27].
These transcription factors control mRNA expression of a
variety of cytokines and secretion of proinflammatory
cytokines, such as TNF-α, IL-1β, and IL-12 [28]. These
cytokines are considered to exert proinflammatory activi-
ties both in septic and aseptic arthritides [16–20].
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Figure 1
Hybridization in situ of synovium from the knee of an arthritic mouse,
showing expression of TNF-α mRNA 3 d after intra-articular injection of
ODN 1668.
Figure 2
Kinetics of synovial cytokine mRNA expression in knees of mice given
an intra-articular injection (6 µg) of CpG ODN. (a) IFN-γ and IL-1β; 
(b) TNF-α and IL-12. Each bar represents the mean number and SEM
of stained cells per mm2 in synovial tissue from four mice for each
interval after inoculation.
TNF-α is produced primarily by monocytes and
macrophages and acts as a mediator of inflammation and
host responses to invasion by microbes [29]. It activates
endothelial cells, upregulates expression of adhesion mol-
ecules, and stimulates macrophage production of IL-1
[29]. IL-1 and TNF-α act synergistically, stimulating each
other’s release and thereby amplifying the cascade of
other inflammatory mediators [16]. High levels of TNF-α
and IL-1 are found in the joints of patients with rheuma-
toid arthritis and such experimental arthritides as colla-
gen-induced arthritis and septic arthritis [11–14]. A
single intra-articular injection of IL-1β or TNF-α can
induce acute synovitis [30,31]. In collagen-induced arthri-
tis, neutralization of TNF-α and IL-1 lessens inflammation
and joint destruction [32,33]. The incidence and severity
of this arthritis are reduced significantly in TNF-α knock-
out mice [10].
IL-12 is a heterodimer consisting of two disulfide-linked
subunits (P35 and P40). It is produced mainly by mono-
cytes and macrophages, mostly in response to microbes.
It induces differentiation of Th1 cells and the production of
IFN-γ by NK and T cells. It takes part in the inflammatory
cascade during the development of synovitis. Previous
studies have shown that the role of IL-12 in the develop-
ment of collagen-induced arthritis appears to depend










Incidence and severity of arthritis in knees of IL-12 knockout mice 
(IL-12–/–) (n = 8) in comparison with their wild-type littermates 
(IL-12+/+) (n = 9), 3 d after intra-articular inoculation with 6 µg CpG
ODN. (a) Incidence. (b) Severity. NS = not significant.
Figure 4
Expression of cytokine mRNA in synovial tissue from knees of IL-12
knockout mice (IL-12–/–) in comparison with their wild-type littermates
(IL-12+/+), 3 d after intra-articular inoculation with 6 µg CpG ODN.
Each bar represents the mean number and SEM of positive cells per
mm2 in synovial tissue from four mice. NS = not significant.
Figure 5
TNF-α production in vitro by spleen mononuclear cells from IL-12
knockout mice (IL-12–/–) in comparison with cells from their wild-type
littermates (IL-12+/+), after stimulation with CpG ODN (1 µM) or
lipopolysaccharides (LPS) (1 µg/ml). Values are means and SEM from
three mice per group. *P < 0.05. NS = not significant.
administration, its dosage, and the immunization protocol
used [33,34]. In addition, mice that are genetically unable
to produce IL-12 display a decreased incidence of septic
arthritis [35]. The present study shows sustained expres-
sion of IL-12 mRNA in synovia of mice with CpG ODN-
triggered arthritis. Histopathological examination revealed
that both the incidence and the severity of arthritis in IL-12
knockout mice were approximately half those in control
animals, although the large within-group variation kept this
difference from reaching statistical significance (see
Fig. 3b). Taken altogether, these data suggest that IL-12
plays a role in the pathogenesis of arthritis triggered by
CpG ODN. Further experiments should be performed to
confirm this relation.
How might IL-12 contribute to the induction of CpG ODN-
triggered arthritis? Previous studies showed that it might
exert its influence in three ways. First, IFN-γ is an important
intermediate for the action of IL-12, which is known to be
able to induce IFN-γ production by NK and T cells [36].
However, our data show that IFN-γ mRNA was expressed
neither in wild-type nor in IL-12 knockout mice. This
finding suggests that the amelioration of CpG ODN-trig-
gered arthritis in IL-12 knockout mice was not due to
downregulation of IFN-γ production. A second possible
means by which IL-12 exerts its influence is through its
upregulation of B-cell production of autoantibodies
[14,37]. Again, our previous studies revealed that B cells
are not important for induction of this arthritis [10]. Finally,
IL-12 could be thought to promote arthritis by favoring the
production of proinflammatory cytokines other than IFN-γ.
Indeed, previous studies in a model of pulmonary
mycobacterial infection suggested that IL-12 is necessary
for the local release of TNF-α [38,39], and that neutraliza-
tion of IL-12 using monoclonal antibodies lowers produc-
tion of TNF-α. We have recently shown that TNF-α is of
importance in mediation of both septic [19] and
CpG ODN-triggered arthritis [10]. In contrast to
macrophage-derived cytokines, IFN-γ mRNA expression
was not detected in arthritic synovia. This finding is not
surprising, since there is a scarcity of T cells, a major
source of IFN-γ, in CpG ODN-triggered arthritis [10], and
NK cells are not important mediators for this arthritis [40].
Our data present in situ cytokine expression in CpG ODN-
triggered arthritis. In the light of these data, we believe that
IL-12, one of the cytokines produced in joints, has pro-
inflammatory properties.
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